These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime. Marchisio ML; Liebrenz KI; Méndez ELA; Di Conza JA Braz J Microbiol; 2021 Dec; 52(4):1853-1863. PubMed ID: 34269999 [TBL] [Abstract][Full Text] [Related]
9. Determining the Orientation of Porins in Planar Lipid Bilayers. Ionescu SA; Lee S; Bayley H Methods Mol Biol; 2021; 2186():51-62. PubMed ID: 32918729 [TBL] [Abstract][Full Text] [Related]
10. Pore formation by pho-controlled outer-membrane proteins of various Enterobacteriaceae in lipid bilayers. Bauer K; Schmid A; Boos W; Benz R; Tommassen J Eur J Biochem; 1988 May; 174(1):199-205. PubMed ID: 2453363 [TBL] [Abstract][Full Text] [Related]
11. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679 [TBL] [Abstract][Full Text] [Related]
12. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Yigit H; Anderson GJ; Biddle JW; Steward CD; Rasheed JK; Valera LL; McGowan JE; Tenover FC Antimicrob Agents Chemother; 2002 Dec; 46(12):3817-22. PubMed ID: 12435682 [TBL] [Abstract][Full Text] [Related]
13. Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects. Sallmann FR; Baveye-Descamps S; Pattus F; Salmon V; Branza N; Spik G; Legrand D J Biol Chem; 1999 Jun; 274(23):16107-14. PubMed ID: 10347162 [TBL] [Abstract][Full Text] [Related]
14. Directed epitope delivery across the Escherichia coli outer membrane through the porin OmpF. Housden NG; Wojdyla JA; Korczynska J; Grishkovskaya I; Kirkpatrick N; Brzozowski AM; Kleanthous C Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21412-7. PubMed ID: 21098297 [TBL] [Abstract][Full Text] [Related]
15. High salt concentrations increase permeability through OmpC channels of Escherichia coli. Kojima S; Nikaido H J Biol Chem; 2014 Sep; 289(38):26464-26473. PubMed ID: 25086034 [TBL] [Abstract][Full Text] [Related]
16. Structural relatedness of enteric bacterial porins assessed with monoclonal antibodies to Salmonella typhimurium OmpD and OmpC. Singh SP; Upshaw Y; Abdullah T; Singh SR; Klebba PE J Bacteriol; 1992 Mar; 174(6):1965-73. PubMed ID: 1312535 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis of porin selectivity: membrane experiments with OmpC-PhoE and OmpF-PhoE hybrid proteins of Escherichia coli K-12. Benz R; Schmid A; Van der Ley P; Tommassen J Biochim Biophys Acta; 1989 May; 981(1):8-14. PubMed ID: 2470409 [TBL] [Abstract][Full Text] [Related]
18. Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel. Simonet V; Malléa M; Pagès JM Antimicrob Agents Chemother; 2000 Feb; 44(2):311-5. PubMed ID: 10639355 [TBL] [Abstract][Full Text] [Related]
19. Exploring the permeation of fluoroquinolone metalloantibiotics across outer membrane porins by combining molecular dynamics simulations and a porin-mimetic in vitro model. Sousa CF; Coimbra JTS; Richter R; Morais-Cabral JH; Ramos MJ; Lehr CM; Fernandes PA; Gameiro P Biochim Biophys Acta Biomembr; 2022 Mar; 1864(3):183838. PubMed ID: 34896074 [TBL] [Abstract][Full Text] [Related]
20. Defining Substrate Specificity in the CTX-M Family: the Role of Asp240 in Ceftazidime Hydrolysis. Ghiglione B; Rodríguez MM; Curto L; Brunetti F; Dropa M; Bonomo RA; Power P; Gutkind G Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]